C128H113ClFN25O16 — CID 160744310
6-(2-chloro-3-fluoro-5-hydroxyphenyl)-2-(1-prop-2-enoylazetidin-3-yl)-3H-isoindol-1-one;6-(2-ethyl-5-methylpyrimidin-4-yl)-2-(1-prop-2-enoylazetidin-3-yl)-3H-isoindol-1-one;6-(5-methyl-1H-indazol-4-yl)-2-(1-prop-2-enoylazetidin-3-yl)-4-(2H-tetrazol-5-yl)-3H-isoindol-1-one;6-(5-methyl-2-oxo-1H-pyrimidin-6-yl)-2-(1-prop-2-enoylazetidin-3-yl)-3H-isoindol-1-one;1-[3-oxo-2-(1-prop-2-enoylazetidin-3-yl)-1H-isoindol-5-yl]-2H-isoquinolin-3-one;4-[3-oxo-2-(1-prop-2-enoylazetidin-3-yl)-1H-isoindol-5-yl]-1H-quinazolin-2-one (PubChem CID 160744310) has the molecular formula C128H113ClFN25O16 and a molecular weight of 2311.92 g/mol. Its IUPAC name is 6-(2-chloro-3-fluoro-5-hydroxyphenyl)-2-(1-prop-2-enoylazetidin-3-yl)-3H-isoindol-1-one;6-(2-ethyl-5-methylpyrimidin-4-yl)-2-(1-prop-2-enoylazetidin-3-yl)-3H-isoindol-1-one;6-(5-methyl-1H-indazol-4-yl)-2-(1-prop-2-enoylazetidin-3-yl)-4-(2H-tetrazol-5-yl)-3H-isoindol-1-one;6-(5-methyl-2-oxo-1H-pyrimidin-6-yl)-2-(1-prop-2-enoylazetidin-3-yl)-3H-isoindol-1-one;1-[3-oxo-2-(1-prop-2-enoylazetidin-3-yl)-1H-isoindol-5-yl]-2H-isoquinolin-3-one;4-[3-oxo-2-(1-prop-2-enoylazetidin-3-yl)-1H-isoindol-5-yl]-1H-quinazolin-2-one.
| Compound Name | 6-(2-chloro-3-fluoro-5-hydroxyphenyl)-2-(1-prop-2-enoylazetidin-3-yl)-3H-isoindol-1-one;6-(2-ethyl-5-methylpyrimidin-4-yl)-2-(1-prop-2-enoylazetidin-3-yl)-3H-isoindol-1-one;6-(5-methyl-1H-indazol-4-yl)-2-(1-prop-2-enoylazetidin-3-yl)-4-(2H-tetrazol-5-yl)-3H-isoindol-1-one;6-(5-methyl-2-oxo-1H-pyrimidin-6-yl)-2-(1-prop-2-enoylazetidin-3-yl)-3H-isoindol-1-one;1-[3-oxo-2-(1-prop-2-enoylazetidin-3-yl)-1H-isoindol-5-yl]-2H-isoquinolin-3-one;4-[3-oxo-2-(1-prop-2-enoylazetidin-3-yl)-1H-isoindol-5-yl]-1H-quinazolin-2-one |
|---|---|
| PubChem CID | 160744310 |
| Molecular Formula | C128H113ClFN25O16 |
| Molecular Weight | 2311.92 g/mol |
| Exact Mass | 2309.85 |
| IUPAC Name | 6-(2-chloro-3-fluoro-5-hydroxyphenyl)-2-(1-prop-2-enoylazetidin-3-yl)-3H-isoindol-1-one;6-(2-ethyl-5-methylpyrimidin-4-yl)-2-(1-prop-2-enoylazetidin-3-yl)-3H-isoindol-1-one;6-(5-methyl-1H-indazol-4-yl)-2-(1-prop-2-enoylazetidin-3-yl)-4-(2H-tetrazol-5-yl)-3H-isoindol-1-one;6-(5-methyl-2-oxo-1H-pyrimidin-6-yl)-2-(1-prop-2-enoylazetidin-3-yl)-3H-isoindol-1-one;1-[3-oxo-2-(1-prop-2-enoylazetidin-3-yl)-1H-isoindol-5-yl]-2H-isoquinolin-3-one;4-[3-oxo-2-(1-prop-2-enoylazetidin-3-yl)-1H-isoindol-5-yl]-1H-quinazolin-2-one |
| SMILES | C=CC(=O)N1CC(N2Cc3c(cc(-c4c(C)ccc5[nH]ncc45)cc3-c3nn[nH]n3)C2=O)C1.C=CC(=O)N1CC(N2Cc3ccc(-c4[nH]c(=O)cc5ccccc45)cc3C2=O)C1.C=CC(=O)N1CC(N2Cc3ccc(-c4[nH]c(=O)ncc4C)cc3C2=O)C1.C=CC(=O)N1CC(N2Cc3ccc(-c4cc(O)cc(F)c4Cl)cc3C2=O)C1.C=CC(=O)N1CC(N2Cc3ccc(-c4nc(=O)[nH]c5ccccc45)cc3C2=O)C1.C=CC(=O)N1CC(N2Cc3ccc(-c4nc(CC)ncc4C)cc3C2=O)C1 |
| InChI | InChI=1S/C23H20N8O2.C23H19N3O3.C22H18N4O3.C21H22N4O2.C20H16ClFN2O3.C19H18N4O3/c1-3-20(32)30-9-14(10-30)31-11-18-15(22-26-28-29-27-22)6-13(7-16(18)23(31)33)21-12(2)4-5-19-17(21)8-24-25-19;1-2-21(28)25-12-17(13-25)26-11-16-8-7-15(9-19(16)23(26)29)22-18-6-4-3-5-14(18)10-20(27)24-22;1-2-19(27)25-11-15(12-25)26-10-14-8-7-13(9-17(14)21(26)28)20-16-5-3-4-6-18(16)23-22(29)24-20;1-4-18-22-9-13(3)20(23-18)14-6-7-15-10-25(21(27)17(15)8-14)16-11-24(12-16)19(26)5-2;1-2-18(26)23-9-13(10-23)24-8-12-4-3-11(5-16(12)20(24)27)15-6-14(25)7-17(22)19(15)21;1-3-16(24)22-9-14(10-22)23-8-13-5-4-12(6-15(13)18(23)25)17-11(2)7-20-19(26)21-17/h3-8,14H,1,9-11H2,2H3,(H,24,25)(H,26,27,28,29);2-10,17H,1,11-13H2,(H,24,27);2-9,15H,1,10-12H2,(H,23,24,29);5-9,16H,2,4,10-12H2,1,3H3;2-7,13,25H,1,8-10H2;3-7,14H,1,8-10H2,2H3,(H,20,21,26) |
| InChIKey | RVZNWAKTFMEPDM-UHFFFAOYSA-N |
| XLogP | 13.23 |
| TPSA | 497.23 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 24 |
| Rotatable Bonds | 20 |
| Heavy Atoms | 171 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2311.92 |
| LogP ≤ 5 | 13.23 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 24 |
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|